Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
| Image |  |
|---|---|
| Description | scientific article published on 20 December 2011 |
| Author/s |
author: Jun Wada |
| Publication date | December 20, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |